Stablepharma Board Announcements

Following the outstanding success of our recent £1.35m equity raise, StablePharma (www.stablepharma.com) is bringing a patented device to market that stands to significantly improve the way most vaccines are distributed globally, which will eliminate the current c. 50% wastage.

Now, that we have our first clinical trials in humans underway, Stablepharma is delighted to announce additional strategic roles to the board. The creation of a strong Leadership Team is of particular and timely significance to Stablepharma, as we grow and develop our business with the invention of the StablevaX™ brand, and its global positioning as a disrupter in the world of vaccination.

Ozgur Tuncer – Board Director, Stablepharma Ltd

Ozgur is a Global Vice President at IQVIA Consulting Services, a member of the Global Leadership Team (GLT) and a global leader for IQVIA’s Financial Institutions Consulting (FIC). In that capacity, he is advising the world's largest and most influential healthcare investors. Stablepharma are delighted to welcome Ozgur onto the board.

As a Director of the Board of Stablepharma and working closely with the Advisory Board, Özgür is in a prime position to drive both growth and investment, as Stablepharma looks to commercialise the StablevaX™ brand and form partnerships around the world.

He is a strategic advisor to healthcare investors and the life sciences industry, an expert in corporate strategy, M&A, new product development and portfolio management. With his focus and strategic insights into the healthcare industry and, his commitment to Stablepharma’s success, Ozgur is a great addition to the board.

Neil Mayall – Financial Director, Stablepharma Ltd

A highly experienced financial services consultant with a passion for doing the right thing, to the best quality – Neil is an experienced financial advisor to the Board of Stablepharma.

With over 30 years of experience as a consultant and consulting practice leader within the Financial Services industry, Neil has worked with major blue chips and start ups and understands the impact that risk can dictate on the success or failure of a business.

Neil brings a wealth of experience to the company with a particular background in operations, product distribution and growth strategies. He is passionate about understanding the challenges and objectives of a business, and then applying his experience, analytical skills and delivery drive to achieve real improvements rapidly. 

Charlie Goddard – Director of Operations & Company Secretary, Stablepharma Ltd

A result focused senior advisor and consultant with 20+ years’ experience in the financial services industry and start up communities. Charlie’s deep expertise and understanding of the complexity of change, business growth and specialism in all aspects of outsourcing is a great addition to the Board of Stablepharma.

He specialises in programme architecture, delivery & implementation, supporting organisations to ensure best in class business growth and ground-breaking outsourcing infrastructures.

As an integral part of the Board of Stablepharma, Charlie is well positioned to drive the development of the company’s corporate strategy and flow of operations information to ensure key objectives are met and delivered and all necessary policies and procedures are in place